Search

Leila Sevigny Phones & Addresses

  • 30 Granite St, Hopkinton, MA 01748
  • Westborough, MA
  • Somerville, MA
  • Westford, VT
  • Winooski, VT
  • Medford, MA
  • Westford, VT
  • Storrs Mansfield, CT

Work

Company: Genzyme, a sanofi company Mar 2013 Address: Greater Boston Area Position: Staff scientist

Education

Degree: PhD School / High School: Tufts University 2005 to 2011 Specialities: Genetics

Languages

English

Industries

Research

Resumes

Resumes

Leila Sevigny Photo 1

Senior Scientist In Bioanalytics Characterization

View page
Location:
138 Cambridge Rd, Westford, VT
Industry:
Research
Work:
Genzyme, a Sanofi Company - Greater Boston Area since Mar 2013
Staff Scientist

MassBiologics - Greater Boston Area May 2011 - Mar 2013
R&D Scientist

Tufts University Sep 2005 - May 2011
PhD Candidate Tufts University School of Medicine

University of Vermont Jun 2004 - Aug 2005
Research Technician
Education:
Tufts University 2005 - 2011
PhD, Genetics
The University of Connecticut 2000 - 2004
BS, Molecular Cell Biology
Languages:
English

Publications

Us Patents

Multispecific Binding Molecules Having Specificity To Dystroglycan And Laminin-2

View page
US Patent:
20180237511, Aug 23, 2018
Filed:
Feb 16, 2018
Appl. No.:
15/932251
Inventors:
- Paris, FR
William H. Brondyk - Mansfield MA, US
Yangde Chen - Wellesley MA, US
Seng H. Cheng - Natick MA, US
Timothy D. Connors - Shrewsbury MA, US
Catherine Devaud - Malakoff, FR
Dietmar Hoffmann - Ashland MA, US
Christian Lange - Frankfurt am Main, DE
Maureen Magnay - Westborough MA, US
Tristan Magnay - Westborough MA, US
Catherine Prades - Choisy le Roi, FR
Ercole Rao - Morfelden-Walldorf, DE
Leila Sevigny - Westborough MA, US
Ronnie Wei - Needham MA, US
Hongmei Zhao - Southborough MA, US
Yunxiang Zhu - Wayland MA, US
International Classification:
C07K 16/18
C07K 16/28
A61P 21/00
Abstract:
Provided herein multispecific (e.g., bispecific) binding molecules comprising a first binding domain that binds an extracellular portion of dystroglycan and a second binding domain that binds laminin-2. Further provided herein are methods for making such binding molecules and uses of such binding molecules for treating and/or preventing alpha-dystroglycanopathies.
Leila M Sevigny from Hopkinton, MA, age ~42 Get Report